GERD and Asthma in Kids: Any Connection? - Medscape News
25 May 2012, 11:04 am
Our commentary today covers the study "lansoprazole for Children With Poorly Controlled Asthma: A Randomized Controlled Trial," from Drs. Holbrook and colleagues, published in the Journal of the American Medical Association. [1] The Faculty of ...

Lifecoach: What is causing my burning throat? - Daily Telegraph
23 May 2012, 6:27 am
Dietary or other triggers can also cause it to relax. Proton-pump inhibitors (PPIs), such as omeprazole and lansoprazole are extremely effective at switching off stomach acid production and treating GORD symptoms, and are among the most prescribed drugs in ...

Rupee weak, Sensex jumps at start: Will rally be sustained? - firstpost.com
21 May 2012, 9:24 pm
Dr Reddy’s Laboratories said it has launched its generic version of lansoprazole delayed-release capsules used for treating acidity and heartburns in the US market. As per a petroleum ministry communication to oil retailers, IOC would get ...

Dr Reddy''s launches lansoprazole capsules in US market - MSN India
21 May 2012, 7:34 am
New Delhi, May 21 (PTI) Drug firm Dr Reddy''s Laboratories today said it has launched its generic version of lansoprazole delayed-release capsules used for treating acidity and heartburns in the US market. The company has launched over-the-counter ...

Research and Markets: Peptic Ulcer Therapeutics - Pipeline Assessment and Market Forecasts to 2018 - Business Wire
21 May 2012, 6:43 am
The peptic ulcer market is well served by Proton Pump Inhibitors (PPIs), which form the majority. PPIs include omeprazole, lansoprazole, pantoprazole, Nexium (esomeprazole) and Aciphex (rabeprazole); and histamine blockers such as ranitidine, nizatidine ...

Dr. Reddy's launches OTC lansoprazole delayed-release capsules in the U.S. - News-Medical.Net
21 May 2012, 1:00 am
Dr. Reddy's Laboratories (NYSE: RDY) announced today that it has launched over-the-counter (OTC) lansoprazole delayed-release capsules in the U.S. market on May 18, 2012, following Dr. Reddy's ANDA approval by the United States Food & Drug ...

Indian Shares Higher For Third Day - NASDAQ
20 May 2012, 11:34 pm
Dr Reddys Laboratories is edging up 0.2 percent after the pharma major launched lansoprazole delayed-release capsules in the U.S. market. HDFC is adding 1.6 percent after its board approved an enabling resolution that increases the limit of ...

Perrigo gets US FDA nod for lansoprazole capsules - pharmabiz.com
20 May 2012, 11:27 pm
Perrigo Company, a leading global healthcare supplier, has received final approval from the US Food and Drug Administration (FDA) for its abbreviated new drug application (ANDA) for lansoprazole capsules (15 mg). Shipments of product to customers have ...

Dr. Reddy's Announces the Launch of Over-the-Counter lansoprazole Delayed-Release Capsules - Marketwatch
20 May 2012, 11:12 pm
HYDERABAD, India, May 21, 2012 (BUSINESS WIRE) -- Dr. Reddy's Laboratories (NYSE:RDY) announced today that it has launched over-the-counter (OTC) lansoprazole delayed-release capsules in the U.S. market on May 18, 2012, following Dr. Reddy's ...

Perrigo Announces FDA Final Approval and Launch of Store Brand OTC lansoprazole 15mg Capsules - Yahoo Finance
18 May 2012, 12:31 pm
ALLEGAN, Mich., May 18, 2012 /PRNewswire/ -- Perrigo Company (Nasdaq: PRGO;TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application (ANDA) for lansoprazole ...